T1	Participants 64 92	heart transplant recipients.
T2	Participants 476 504	heart-transplant recipients.
T3	Participants 513 605	Twenty heart-transplant recipients were randomised into either a treated or a placebo group.
T4	Participants 1227 1356	one patient in the ticlopidine group was withdrawn because of a major fall in cyclosporin blood level within 3 days of treatment.
